156 related articles for article (PubMed ID: 38519982)
1. Regional disparities and risk factors of mortality among patients at high risk of sudden cardiac death in emerging countries: a nonrandomized controlled trial.
Zhao S; Ching CK; Huang D; Liu YB; Rodriguez-Guerrero DA; Hussin A; Kim YH; Van Dorn B; Zhou X; Singh B; Zhang S;
BMC Med; 2024 Mar; 22(1):130. PubMed ID: 38519982
[TBL] [Abstract][Full Text] [Related]
2. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Use of Implantable Cardioverter-Defibrillators in the Prevention of Sudden Cardiac Death in Dialysis Patients.
Jukema JW; Timal RJ; Rotmans JI; Hensen LCR; Buiten MS; de Bie MK; Putter H; Zwinderman AH; van Erven L; Krol-van Straaten MJ; Hommes N; Gabreëls B; van Dorp W; van Dam B; Herzog CA; Schalij MJ; Rabelink TJ;
Circulation; 2019 Jun; 139(23):2628-2638. PubMed ID: 30882234
[TBL] [Abstract][Full Text] [Related]
4. Utilization of implantable cardioverter-defibrillators for the prevention of sudden cardiac death in emerging countries: Improve SCA clinical trial.
Zhang S; Ching CK; Huang D; Liu YB; Rodriguez-Guerrero DA; Hussin A; Kim YH; Chasnoits AR; Cerkvenik J; Lexcen DR; Muckala K; Brown ML; Cheng A; Singh B;
Heart Rhythm; 2020 Mar; 17(3):468-475. PubMed ID: 31561030
[TBL] [Abstract][Full Text] [Related]
5. Predictors of primary prevention implantable cardioverter-defibrillator use in heart failure with reduced ejection fraction: impact of the predicted risk of sudden cardiac death and all-cause mortality.
Schrage B; Lund LH; Benson L; Dahlström U; Shadman R; Linde C; Braunschweig F; Levy WC; Savarese G
Eur J Heart Fail; 2022 Jul; 24(7):1212-1222. PubMed ID: 35502681
[TBL] [Abstract][Full Text] [Related]
6. Identification of patients at risk of sudden cardiac death in congenital heart disease: The PRospEctiVE study on implaNTable cardIOverter defibrillator therapy and suddeN cardiac death in Adults with Congenital Heart Disease (PREVENTION-ACHD).
Vehmeijer JT; Koyak Z; Leerink JM; Zwinderman AH; Harris L; Peinado R; Oechslin EN; Robbers-Visser D; Groenink M; Boekholdt SM; de Winter RJ; Oliver JM; Bouma BJ; Budts W; Van Gelder IC; Mulder BJM; de Groot JR
Heart Rhythm; 2021 May; 18(5):785-792. PubMed ID: 33465514
[TBL] [Abstract][Full Text] [Related]
7. Sacubitril/Valsartan and Sudden Cardiac Death According to Implantable Cardioverter-Defibrillator Use and Heart Failure Cause: A PARADIGM-HF Analysis.
Rohde LE; Chatterjee NA; Vaduganathan M; Claggett B; Packer M; Desai AS; Zile M; Rouleau J; Swedberg K; Lefkowitz M; Shi V; McMurray JJV; Solomon SD
JACC Heart Fail; 2020 Oct; 8(10):844-855. PubMed ID: 32919916
[TBL] [Abstract][Full Text] [Related]
8. Worldwide differences in primary prevention implantable cardioverter defibrillator utilization and outcomes in hypertrophic cardiomyopathy.
Nauffal V; Marstrand P; Han L; Parikh VN; Helms AS; Ingles J; Jacoby D; Lakdawala NK; Kapur S; Michels M; Owens AT; Ashley EA; Pereira AC; Rossano JW; Saberi S; Semsarian C; Ware JS; Wittekind SG; Day S; Olivotto I; Ho CY
Eur Heart J; 2021 Oct; 42(38):3932-3944. PubMed ID: 34491319
[TBL] [Abstract][Full Text] [Related]
9. Incidence of Sudden Cardiac Death and Life-Threatening Arrhythmias in Clinically Manifest Cardiac Sarcoidosis With and Without Current Indications for an Implantable Cardioverter Defibrillator.
Nordenswan HK; Pöyhönen P; Lehtonen J; Ekström K; Uusitalo V; Niemelä M; Vihinen T; Kaikkonen K; Haataja P; Kerola T; Rissanen TT; Alatalo A; Pietilä-Effati P; Kupari M
Circulation; 2022 Sep; 146(13):964-975. PubMed ID: 36000392
[TBL] [Abstract][Full Text] [Related]
10. Association of Implantable Cardioverter Defibrillators With Survival in Patients With and Without Improved Ejection Fraction: Secondary Analysis of the Sudden Cardiac Death in Heart Failure Trial.
Adabag S; Patton KK; Buxton AE; Rector TS; Ensrud KE; Vakil K; Levy WC; Poole JE
JAMA Cardiol; 2017 Jul; 2(7):767-774. PubMed ID: 28724134
[TBL] [Abstract][Full Text] [Related]
11. Improving the utilization of implantable cardioverter defibrillators for sudden cardiac arrest prevention (Improve SCA) in developing countries: Clinical characteristics and reasons for implantation refusal.
Singh B; Zhang S; Ching CK; Huang D; Liu YB; Rodriguez DA; Hussin A; Kim YH; Chasnoits AR; Cerkvenik J; Muckala KA; Cheng A
Pacing Clin Electrophysiol; 2018 Dec; 41(12):1619-1626. PubMed ID: 30320410
[TBL] [Abstract][Full Text] [Related]
12. Preventive effectiveness of implantable cardioverter defibrillator in reducing sudden cardiac death in the Chinese population: a multicenter trial of ICD therapy versus non-ICD therapy.
Hua W; Niu H; Fan X; Ding L; Xu YZ; Wang J; Chen K; Wang F; Zhang S;
J Cardiovasc Electrophysiol; 2012 Nov; 23 Suppl 1():S5-9. PubMed ID: 23140347
[TBL] [Abstract][Full Text] [Related]
13. Predicting therapies in Japanese hypertrophic cardiomyopathy patients with an implantable cardioverter-defibrillator using the 2014 European Society of Cardiology guidelines.
Nakano M; Kondo Y; Nakano M; Kajiyama T; Miyazawa K; Hayashi T; Ito R; Takahira H; Kobayashi Y
Heart Vessels; 2021 Jan; 36(1):99-104. PubMed ID: 32666207
[TBL] [Abstract][Full Text] [Related]
14. The mortality analysis of primary prevention patients receiving a cardiac resynchronization defibrillator (CRT-D) or implantable cardioverter-defibrillator (ICD) according to guideline indications in the improve SCA study.
Ching CK; Hsieh YC; Liu YB; Rodriguez DA; Kim YH; Joung B; Singh B; Huang D; Hussin A; Chasnoits AR; O'Brien JE; Cerkvenik J; Lexcen D; Van Dorn B; Zhang S
J Cardiovasc Electrophysiol; 2021 Aug; 32(8):2285-2294. PubMed ID: 34216069
[TBL] [Abstract][Full Text] [Related]
15. Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
Fishbein DP; Hellkamp AS; Mark DB; Walsh MN; Poole JE; Anderson J; Johnson G; Lee KL; Bardy GH;
J Am Coll Cardiol; 2014 Jun; 63(23):2560-2568. PubMed ID: 24727258
[TBL] [Abstract][Full Text] [Related]
16. Impact of implantable cardioverter-defibrillator, amiodarone, and placebo on the mode of death in stable patients with heart failure: analysis from the sudden cardiac death in heart failure trial.
Packer DL; Prutkin JM; Hellkamp AS; Mitchell LB; Bernstein RC; Wood F; Boehmer JP; Carlson MD; Frantz RP; McNulty SE; Rogers JG; Anderson J; Johnson GW; Walsh MN; Poole JE; Mark DB; Lee KL; Bardy GH
Circulation; 2009 Dec; 120(22):2170-6. PubMed ID: 19917887
[TBL] [Abstract][Full Text] [Related]
17. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government.
Anderson KP
J Interv Card Electrophysiol; 2005 Nov; 14(2):71-8. PubMed ID: 16374553
[TBL] [Abstract][Full Text] [Related]
18. Improve the Prevention of Sudden Cardiac Arrest in Patients With Post-Acute Myocardial Infarction.
Zhang S; Chen WJ; Sankardas MA; Ahmed WH; Liew HB; Gwon HC; Nesa Malik FT; Tang B; Haggui A; Oh IY; Ong TK; Cheng CI; Liu X; Seth A; Choi YJ; Qamar N; Rungpradubvong V; Wang CC; Jeon J; Wong G; Lemme F; Van Dorn B; Lexcen D; Huang D;
JACC Asia; 2022 Oct; 2(5):559-571. PubMed ID: 36518723
[TBL] [Abstract][Full Text] [Related]
19. Survival After Secondary Prevention Implantable Cardioverter-Defibrillator Placement: An Analysis From the NCDR ICD Registry.
Katz DF; Peterson P; Borne RT; Betz J; Al-Khatib SM; Varosy PD; Wang Y; Hsu JC; Hoffmayer KS; Kipp RT; Hansen CM; Turakhia MP; Masoudi FA
JACC Clin Electrophysiol; 2017 Jan; 3(1):20-28. PubMed ID: 29759690
[TBL] [Abstract][Full Text] [Related]
20. Outcomes for patients with anterior myocardial infarction and prior cardiac arrest in the home automated external defibrillator trial (HAT).
Starks MA; Jackson LR; Hellkamp A; Al-Khatib SM; Mark DB; Thomas KL; Nichol G; Lee KL; Davidson-Ray L; Poole J; Anderson J; Johnson G; Bardy GH
Resuscitation; 2021 Nov; 168():75-83. PubMed ID: 34500022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
